BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
titan biotech ltd. stock

TITAN BIOTECH LTD. Share Price

796.65 -19.39 (-2.37%)
Dec 11 2024 03:30 PM Pharmaceuticals NSE: TITANBIO

TITAN BIOTECH LTD. Share Price Update

As of the latest trading session, TITAN BIOTECH LTD. share price is currently at 796.65, which is down by -19.39 from its previous closing. Today, the stock has fluctuated between 790.00 and 837.90. Over the past year, TITAN BIOTECH LTD. has achieved a return of 106.38 %. In the last month alone, the return has been -6.98 %. Read More...

TITAN BIOTECH LTD. Performance

Day Range

Low790.00 High837.90
796.65

52 Week Range

Low 396.00 High 1017.85
796.65

TITAN BIOTECH LTD. Share Price

524717

TITANBIO

img img img img
No Data Available

Open Price

837.90

Prev. Close

816.05

Volume (Shares)

6897.00

Total traded value

55.65

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

TITAN BIOTECH LTD. Fundamentals


(Standalone)

Market Cap (Cr) 658.32
PE Ratio (TTM) 28.71
Book Value / Share 166.48
Beta 0.83
ROE 20.18%
EPS (TTM) 27.75
Dividend Yield 0.25%
Net Profit Qtr (Cr) 5.00

TITAN BIOTECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 39.89
Operating Expense 33.50
Net Profit 5.00
Net Profit Margin (%) 12.53
Earnings Per Share (EPS) 6.05
EBITDA 8.09
Effective Tax Rate (%) 25.44
Particulars JUN 2024 (Values in Cr)
Revenue 43.11
Operating Expense 36.22
Net Profit 5.70
Net Profit Margin (%) 13.22
Earnings Per Share (EPS) 6.90
EBITDA 8.87
Effective Tax Rate (%) 24.20
Particulars MAR 2024 (Values in Cr)
Revenue 39.92
Operating Expense 34.02
Net Profit 4.84
Net Profit Margin (%) 12.12
Earnings Per Share (EPS) 5.86
EBITDA 7.55
Effective Tax Rate (%) 24.01
Particulars DEC 2023 (Values in Cr)
Revenue 45.98
Operating Expense 36.47
Net Profit 7.38
Net Profit Margin (%) 16.05
Earnings Per Share (EPS) 8.93
EBITDA 11.03
Effective Tax Rate (%) 25.75
Particulars SEP 2023 (Values in Cr)
Revenue 43.43
Operating Expense 35.85
Net Profit 6.03
Net Profit Margin (%) 13.88
Earnings Per Share (EPS) 7.30
EBITDA 9.27
Effective Tax Rate (%) 25.83
Particulars MAR 2024 (Values in Cr)
Revenue 164.07
Operating Expense 134.29
Net Profit 23.66
Net Profit Margin (%) 14.42
Earnings Per Share (EPS) 28.64
EBITDA 36.03
Effective Tax Rate (%) 24.96
Particulars MAR 2023 (Values in Cr)
Revenue 144.00
Operating Expense 117.83
Net Profit 21.02
Net Profit Margin (%) 14.59
Earnings Per Share (EPS) 25.44
EBITDA 31.47
Effective Tax Rate (%) 25.21
Particulars MAR 2022 (Values in Cr)
Revenue 123.55
Operating Expense 95.52
Net Profit 21.68
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 26.24
EBITDA 32.21
Effective Tax Rate (%) 25.12
Particulars MAR 2021 (Values in Cr)
Revenue 122.46
Operating Expense 84.04
Net Profit 28.77
Net Profit Margin (%) 23.49
Earnings Per Share (EPS) 34.82
EBITDA 42.14
Effective Tax Rate (%) 25.77
Particulars MAR 2020 (Values in Cr)
Revenue 69.48
Operating Expense 62.26
Net Profit 6.20
Net Profit Margin (%) 8.92
Earnings Per Share (EPS) 7.50
EBITDA 11.89
Effective Tax Rate (%) 24.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 161.49
ROE % 19.44
ROCE % 24.84
Total Debt to Total Equity 0.07
EBITDA Margin 21.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 133.00
ROE % 21.43
ROCE % 26.64
Total Debt to Total Equity 0.09
EBITDA Margin 21.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.36
ROE % 27.98
ROCE % 32.66
Total Debt to Total Equity 0.16
EBITDA Margin 26.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.21
ROE % 58.75
ROCE % 59.10
Total Debt to Total Equity 0.37
EBITDA Margin 32.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share 47.43
ROE % 21.97
ROCE % 21.07
Total Debt to Total Equity 0.67
EBITDA Margin 18.32
Particulars MAR 2024 (Values in Cr)
Book Value / Share 155.43
ROE % 20.18
ROCE % 25.70
Total Debt to Total Equity 0.07
EBITDA Margin 21.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.38
ROE % 21.86
ROCE % 27.12
Total Debt to Total Equity 0.09
EBITDA Margin 21.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.36
ROE % 28.52
ROCE % 34.30
Total Debt to Total Equity 0.13
EBITDA Margin 26.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.65
ROE % 55.52
ROCE % 59.73
Total Debt to Total Equity 0.27
EBITDA Margin 34.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share 45.76
ROE % 17.85
ROCE % 18.26
Total Debt to Total Equity 0.57
EBITDA Margin 17.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.84
Total Assets 156.57
Total Liabilities 156.57
Total Equity 133.45
Share Outstanding 8263700
Price to Book Ratio 3.40
Return on Assets (%) 15.87
Return on Capital (%) 17.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 134.51
Total Liabilities 134.51
Total Equity 109.91
Share Outstanding 8263700
Price to Book Ratio 1.53
Return on Assets (%) 18.46
Return on Capital (%) 21.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.81
Total Assets 108.09
Total Liabilities 108.09
Total Equity 86.24
Share Outstanding 8263700
Price to Book Ratio 2.51
Return on Assets (%) 20.06
Return on Capital (%) 23.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.45
Total Assets 100.71
Total Liabilities 100.71
Total Equity 72.47
Share Outstanding 8263700
Price to Book Ratio 2.33
Return on Assets (%) 30.11
Return on Capital (%) 35.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 76.03
Total Liabilities 76.03
Total Equity 41.54
Share Outstanding 8263700
Price to Book Ratio 0.93
Return on Assets (%) 9.29
Return on Capital (%) 10.97
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.84
Total Assets 151.57
Total Liabilities 151.57
Total Equity 128.44
Share Outstanding 8263700
Price to Book Ratio 3.40
Return on Assets (%) 15.61
Return on Capital (%) 17.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 130.69
Total Liabilities 130.69
Total Equity 106.09
Share Outstanding 8263700
Price to Book Ratio 1.53
Return on Assets (%) 16.08
Return on Capital (%) 18.59
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.81
Total Assets 108.09
Total Liabilities 108.09
Total Equity 86.24
Share Outstanding 8263700
Price to Book Ratio 2.51
Return on Assets (%) 20.06
Return on Capital (%) 23.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.30
Total Assets 86.17
Total Liabilities 86.17
Total Equity 65.82
Share Outstanding 8263700
Price to Book Ratio 2.33
Return on Assets (%) 33.39
Return on Capital (%) 39.22
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.72
Total Assets 65.19
Total Liabilities 65.19
Total Equity 37.81
Share Outstanding 8263700
Price to Book Ratio 0.93
Return on Assets (%) 9.51
Return on Capital (%) 11.34
Particulars MAR 2024 (Values in Cr)
Net Income 31.52
Cash from Operations 29.01
Cash from Investing -20.30
Cash from Financing -2.86
Net change in Cash -2.02
Free Cash Flow 48.50
Particulars MAR 2023 (Values in Cr)
Net Income 28.11
Cash from Operations 28.67
Cash from Investing -20.72
Cash from Financing -2.40
Net change in Cash -1.95
Free Cash Flow 31.75
Particulars MAR 2022 (Values in Cr)
Net Income 28.96
Cash from Operations 29.15
Cash from Investing -16.43
Cash from Financing -4.09
Net change in Cash 1.50
Free Cash Flow 35.46
Particulars MAR 2021 (Values in Cr)
Net Income 42.70
Cash from Operations 29.96
Cash from Investing -4.86
Cash from Financing -10.59
Net change in Cash 3.61
Free Cash Flow 32.97
Particulars MAR 2020 (Values in Cr)
Net Income 10.40
Cash from Operations 8.30
Cash from Investing -2.21
Cash from Financing -3.94
Net change in Cash -0.04
Free Cash Flow 8.30
Particulars MAR 2024 (Values in Cr)
Net Income 31.52
Cash from Operations 29.01
Cash from Investing -20.30
Cash from Financing -2.86
Net change in Cash -2.02
Free Cash Flow 48.50
Particulars MAR 2023 (Values in Cr)
Net Income 28.11
Cash from Operations 28.67
Cash from Investing -20.72
Cash from Financing -2.40
Net change in Cash -1.95
Free Cash Flow 31.75
Particulars MAR 2022 (Values in Cr)
Net Income 28.96
Cash from Operations 29.15
Cash from Investing -16.43
Cash from Financing -4.09
Net change in Cash 1.50
Free Cash Flow 35.46
Particulars MAR 2021 (Values in Cr)
Net Income 38.76
Cash from Operations 27.74
Cash from Investing -4.17
Cash from Financing -9.80
Net change in Cash 3.60
Free Cash Flow 30.45
Particulars MAR 2020 (Values in Cr)
Net Income 8.24
Cash from Operations 8.46
Cash from Investing -0.94
Cash from Financing -5.86
Net change in Cash 0.11
Free Cash Flow 9.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 834.50
  • 26 Days 831.30
  • 10 Days 818.40
  • 50 Days 806.90
  • 12 Days 812.90
  • 100 Days 749.50
  • 20 Days 823.20
  • 200 Days 601.90
827.35
PIVOT
First Resistance 853.70
Second Resistance 891.35
Third Resistance 917.70
First Support 789.70
Second Support 763.35
Third Support 725.70
RSI 49.57
MACD -18.42
Commodity Channel Index (CCI) 39.63
ADX 29.43
Williams % R -49.08

Over 1 Month

down

-6.98

Over 3 Months

down

37.32

Over 6 Months

down

49.63

Over 1 Year

down

106.38

Over 3 Years

down

44.75

Over 5 Years

down

87.72

TITAN BIOTECH LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

TITAN BIOTECH LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
44.12
Promoter Holdings
55.87
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Titan Securities Ltd Shareholding of Promoter and Promoter Group 2776155.0 33.59
Tanita Leasing & Finance Limited Shareholding of Promoter and Promoter Group 784455.0 9.49
Connoisseur Management Services Private Limited Shareholding of Promoter and Promoter Group 560000.0 6.78
Manish Goel Public Shareholding 129766.0 1.57
Suresh Chand Singla Shareholding of Promoter and Promoter Group 105671.0 1.28
Manju Singla Shareholding of Promoter and Promoter Group 71210.0 0.86
Madhu Gupta Shareholding of Promoter and Promoter Group 66510.0 0.8
Raja Singla Shareholding of Promoter and Promoter Group 61100.0 0.74
Supriya Singla Shareholding of Promoter and Promoter Group 54493.0 0.66
Udit Singla Shareholding of Promoter and Promoter Group 50000.0 0.61
Shivom Singla Shareholding of Promoter and Promoter Group 35400.0 0.43
Naresh Kumar Singla Shareholding of Promoter and Promoter Group 34510.0 0.42
Naresh Kumar Singla Huf Shareholding of Promoter and Promoter Group 10000.0 0.12
Ravinder Gupta Shareholding of Promoter and Promoter Group 7900.0 0.1
Ravinder Gupta Huf Shareholding of Promoter and Promoter Group 111.0 0.0

TITAN BIOTECH LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 1.8 Final 2023-09-22 Equity shares 2022-09-22 1.5 Final 2022-09-23 Equity shares 2021-09-16 1.5 Final 2021-09-08 Equity shares 2020-09-17 1.0 Final 2020-09-19 Equity shares 2018-09-19 0.75 Final 2018-09-22 Equity shares 2017-09-21 0.75 Final 2017-09-23 Equity shares 2016-09-22 0.75 Final 2016-09-26 Equity shares 2015-09-22 0.75 Final 2015-09-24 Equity shares 2014-09-18 0.75 Final 2014-09-22 Equity shares 2013-09-19 0.75 Final 2013-09-23 Equity shares 2011-09-22 0.75 Final 2011-09-26 Equity shares 2010-09-23 0.5 Final 2010-09-25 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About TITAN BIOTECH LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by TITAN BIOTECH LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Titan Biotech Ltd?

Answer Field

The share price of Titan Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 796.65.

What is the Market Cap of Titan Biotech Ltd?

Answer Field

The market cap of Titan Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 6,58.30 Cr. as of now.

What is the 52 Week High and Low of Titan Biotech Ltd?

Answer Field

The 52 Week High and Low of Titan Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1017.85 and ₹ 396.00.

How to Buy Titan Biotech Ltd share?

Answer Field

You can trade in Titan Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Titan Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 106.38%.

What is the Current Share Price of Titan Biotech Ltd?

Answer Field

Titan Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 796.65 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Titan Biotech Ltd Share?

Answer Field

The market cap of Titan Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 6,58.30 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Titan Biotech Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Titan Biotech Ltd share is 28.71.

What is the PB ratio of Titan Biotech Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Titan Biotech Ltd share is 166.48.

How to Buy Titan Biotech Ltd Share?

Answer Field

You can trade in Titan Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Titan Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Titan Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Titan Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader